Hu, B., Zhou, X., Liu, Y., Li, Q., Xiang, M., Zou, B., . . . Lu, Y. (2018). Comparison of chemotherapy plus bevacizumab vs. chemotherapy alone as third-line treatment or beyond for advanced non-small cell lung cancer: A propensity score-matched analysis. Oncol Lett.
Citação norma ChicagoHu, Binbin, et al. "Comparison of Chemotherapy Plus Bevacizumab Vs. Chemotherapy Alone As Third-line Treatment or Beyond for Advanced Non-small Cell Lung Cancer: A Propensity Score-matched Analysis." Oncol Lett 2018.
Citação norma MLAHu, Binbin, et al. "Comparison of Chemotherapy Plus Bevacizumab Vs. Chemotherapy Alone As Third-line Treatment or Beyond for Advanced Non-small Cell Lung Cancer: A Propensity Score-matched Analysis." Oncol Lett 2018.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.